137 related articles for article (PubMed ID: 16103099)
1. RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines.
Simizu S; Takagi S; Tamura Y; Osada H
Cancer Res; 2005 Aug; 65(16):7455-61. PubMed ID: 16103099
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion.
Liu LT; Chang HC; Chiang LC; Hung WC
Cancer Res; 2003 Jun; 63(12):3069-72. PubMed ID: 12810630
[TBL] [Abstract][Full Text] [Related]
3. RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness.
Kang HG; Kim HS; Kim KJ; Oh JH; Lee MR; Seol SM; Han I
J Orthop Res; 2007 May; 25(5):696-702. PubMed ID: 17262820
[TBL] [Abstract][Full Text] [Related]
4. RECK negatively regulates matrix metalloproteinase-9 transcription.
Takagi S; Simizu S; Osada H
Cancer Res; 2009 Feb; 69(4):1502-8. PubMed ID: 19208844
[TBL] [Abstract][Full Text] [Related]
5. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.
Masui T; Doi R; Koshiba T; Fujimoto K; Tsuji S; Nakajima S; Koizumi M; Toyoda E; Tulachan S; Ito D; Kami K; Mori T; Wada M; Noda M; Imamura M
Clin Cancer Res; 2003 May; 9(5):1779-84. PubMed ID: 12738734
[TBL] [Abstract][Full Text] [Related]
6. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
Takeuchi T; Hisanaga M; Nagao M; Ikeda N; Fujii H; Koyama F; Mukogawa T; Matsumoto H; Kondo S; Takahashi C; Noda M; Nakajima Y
Clin Cancer Res; 2004 Aug; 10(16):5572-9. PubMed ID: 15328199
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.
Correa TC; Brohem CA; Winnischofer SM; da Silva Cardeal LB; Sasahara RM; Taboga SR; Sogayar MC; Maria-Engler SS
J Cell Biochem; 2006 Sep; 99(1):156-67. PubMed ID: 16791855
[TBL] [Abstract][Full Text] [Related]
8. Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
Takemoto N; Tada M; Hida Y; Asano T; Cheng S; Kuramae T; Hamada J; Miyamoto M; Kondo S; Moriuchi T
Lung Cancer; 2007 Dec; 58(3):376-83. PubMed ID: 17714826
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer.
Cho YB; Lee WY; Song SY; Shin HJ; Yun SH; Chun HK
Hum Pathol; 2007 Nov; 38(11):1603-10. PubMed ID: 17669467
[TBL] [Abstract][Full Text] [Related]
11. Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells.
Liu LT; Chang HC; Chiang LC; Hung WC
Oncogene; 2002 Nov; 21(54):8347-50. PubMed ID: 12447698
[TBL] [Abstract][Full Text] [Related]
12. Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation.
Park JM; Kim A; Oh JH; Chung AS
Carcinogenesis; 2007 Apr; 28(4):837-47. PubMed ID: 17071627
[TBL] [Abstract][Full Text] [Related]
13. The ß1-integrin-dependent function of RECK in physiologic and tumor angiogenesis.
Miki T; Shamma A; Kitajima S; Takegami Y; Noda M; Nakashima Y; Watanabe K; Takahashi C
Mol Cancer Res; 2010 May; 8(5):665-76. PubMed ID: 20407016
[TBL] [Abstract][Full Text] [Related]
14. Expression of membrane-anchored matrix metalloproteinase inhibitor reversion inducing cysteine rich protein with Kazal motifs in murine cell lines.
Takagi S; Hoshino Y; Osaki T; Okumura M; Fuginaga T
Exp Oncol; 2007 Mar; 29(1):30-4. PubMed ID: 17431385
[TBL] [Abstract][Full Text] [Related]
15. RECK-mediated inhibition of glioma migration and invasion.
Silveira Corrêa TC; Massaro RR; Brohem CA; Taboga SR; Lamers ML; Santos MF; Maria-Engler SS
J Cell Biochem; 2010 May; 110(1):52-61. PubMed ID: 20127710
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
Oshima T; Kunisaki C; Yoshihara K; Yamada R; Yamamoto N; Sato T; Makino H; Yamagishi S; Nagano Y; Fujii S; Shiozawa M; Akaike M; Wada N; Rino Y; Masuda M; Tanaka K; Imada T
Oncol Rep; 2008 May; 19(5):1285-91. PubMed ID: 18425389
[TBL] [Abstract][Full Text] [Related]
17. Saponins derived from the roots of Platycodon grandiflorum inhibit HT-1080 cell invasion and MMPs activities: regulation of NF-kappaB activation via ROS signal pathway.
Lee KJ; Hwang SJ; Choi JH; Jeong HG
Cancer Lett; 2008 Sep; 268(2):233-43. PubMed ID: 18499341
[TBL] [Abstract][Full Text] [Related]
18. Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer.
Song SY; Son HJ; Nam E; Rhee JC; Park C
Eur J Cancer; 2006 Jan; 42(1):101-8. PubMed ID: 16324834
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Park HJ; Lee HJ; Min HY; Chung HJ; Suh ME; Park-Choo HY; Kim C; Kim HJ; Seo EK; Lee SK
Eur J Pharmacol; 2005 Dec; 527(1-3):31-6. PubMed ID: 16309669
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells.
Cho CY; Wang JH; Chang HC; Chang CK; Hung WC
J Cell Physiol; 2007 Oct; 213(1):65-9. PubMed ID: 17443689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
